Net Loss Per Common Share |
Net Loss Per Common Share The following table presents the calculation of basic and diluted net loss per share attributable to common stockholders for the periods indicated. As the Company reported a net loss, diluted net loss per share was the same as basic net loss per share because the effects of potentially dilutive items were anti-dilutive for all periods presented. | | | | | | | | | | | | | | | | | Three Months Ended March 31, | | | (in thousands, except share and per share amounts) | 2022 | | 2021 | | | | | Numerator: | | | | | | | | | | | | | | | | | | | | | | | | Net loss attributable to common stockholders | $ | (23,310) | | | $ | (7,770) | | | | | | Denominator: | | | | | | | | Weighted-average shares used in computing net loss per share attributable to common stockholders: | | | | | | | | Basic and diluted | 164,391,753 | | 22,711,379 | | | | | | Net loss per share attributable to common stockholders: | | | | | | | | Basic and diluted | $ | (0.14) | | | $ | (0.34) | | | | | |
The following potentially dilutive securities were excluded from the computation of diluted net loss per share calculations for the periods presented because the impact of including them would have been anti-dilutive: | | | | | | | | | | | | | March 31, | | 2022 | | 2021 | Redeemable convertible preferred stock | — | | | 127,410,631 | | Common stock warrants | — | | | 256,250 | | Stock options outstanding | 21,596,404 | | | 20,692,111 | RSUs outstanding(1) | 5,476,101 | | | 617,696 | | ESPP | 1,379,019 | | — | | Shares subject to repurchase | 363,384 | | 1,901,675 | Total | 28,814,908 | | 150,878,363 |
(1) A portion of these RSUs were subject to a performance-based vesting condition until September 22, 2021. See Note 10 for details on these awards.
|